According to Gland Pharma 's latest financial reports the company's current EPS (TTM) is $0.93. In 2022 the company made an earnings per share (EPS) of $1.27 a decrease over its 2021 EPS that were of $1.64.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.91 | -28.17% |
2022 | $1.27 | -22.53% |
2021 | $1.64 | 26.92% |
2020 | $1.29 |